Bio Green Energy Tech Valuation
Is BIOTEC-F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BIOTEC-F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BIOTEC-F (THB8) is trading below our estimate of fair value (THB28.12)
Significantly Below Fair Value: BIOTEC-F is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BIOTEC-F?
Other financial metrics that can be useful for relative valuation.
What is BIOTEC-F's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿763.34m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.4x |
Enterprise Value/EBITDA | 33x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does BIOTEC-F's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1x | ||
AMA Ama Marine | 0.7x | n/a | ฿2.1b |
RP Raja Ferry Port | 0.4x | n/a | ฿230.9m |
PSL Precious Shipping | 2.3x | 4.4% | ฿12.6b |
RCL Regional Container Lines | 0.7x | n/a | ฿17.9b |
BIOTEC-F Bio Green Energy Tech | 0.2x | n/a | ฿763.3m |
Price-To-Sales vs Peers: BIOTEC-F is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (1x).
Price to Earnings Ratio vs Industry
How does BIOTEC-F's PE Ratio compare vs other companies in the Asian Shipping Industry?
Price-To-Sales vs Industry: BIOTEC-F is good value based on its Price-To-Sales Ratio (0.2x) compared to the Asian Shipping industry average (1.5x).
Price to Sales Ratio vs Fair Ratio
What is BIOTEC-F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.2x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate BIOTEC-F's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.